• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MPC-1-CD49e-未成熟骨髓瘤细胞包括CD45+亚群,这些亚群在人类骨髓瘤中可对白细胞介素-6作出反应而增殖。

MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.

作者信息

Fujii R, Ishikawa H, Mahmoud M S, Asaoku H, Kawano M M

机构信息

Department of Immunohaematology, Yamaguchi University School of Medicine, Ube, Japan.

出版信息

Br J Haematol. 1999 Apr;105(1):131-40.

PMID:10233376
Abstract

Using three-colour phenotypic analysis, we detected five subpopulations of myeloma cells (CD38++) in the bone marrow mononuclear cells of human myeloma patients: MPC-1-CD45-CD49e-, MPC-1-CD45+CD49e-, MPC-1+CD45-CD49e-, MPC-1+CD45+CD49e- and MPC-1+CD45+CD49e+. Most of the myeloma cells did not express CD45 but a few MPC-1- immature myeloma cells and some MPC-1+ myeloma cells expressed CD45 and CD45RO but not CD45RA, whereas all of normal early plasma cells in the peripheral blood, lymph node plasma cells and bone marrow plasma cells expressed CD45 and CD45RA, CD45RB but not CD45RO. In order to clarify the biological character of these myeloma subpopulations, we examined the expression of Ki-67 antigen. Proliferating myeloma cells (Ki-67+) were found in the MPC-1- fractions and the MPC-1-CD45+ fractions rather than MPC-1-CD45- fractions. Next, in order to further clarify the biological difference of two immature subpopulations (MPC-1-CD45-CD49e- and MPC-1- CD45+CD49e-), determined cell viability and phenotypic change after culturing with interleukin 6 (IL-6) in vitro. In the presence of IL-6, MPC-1-CD45+ cells kept their viability more than MPC-1-CD45- cells and some MPC-1-CD45- cells could be converted to MPC-1-CD45+ cells. In conclusion, these data suggest that human myeloma cells are phenotypically subdivided into five subpopulations, and among these subpopulations MPC-1-CD45+CD49e- but not MPC-1-CD45-CD49e- immature cells contain proliferating cells in response to IL-6, and IL-6 can also induce expression of CD45 on MPC-1-CD45- subpopulation of immature myeloma cells.

摘要

利用三色表型分析,我们在人类骨髓瘤患者的骨髓单个核细胞中检测到骨髓瘤细胞(CD38++)的五个亚群:MPC-1-CD45-CD49e-、MPC-1-CD45+CD49e-、MPC-1+CD45-CD49e-、MPC-1+CD45+CD49e-和MPC-1+CD45+CD49e+。大多数骨髓瘤细胞不表达CD45,但少数MPC-1-未成熟骨髓瘤细胞和一些MPC-1+骨髓瘤细胞表达CD45和CD45RO,但不表达CD45RA,而外周血中的所有正常早期浆细胞、淋巴结浆细胞和骨髓浆细胞均表达CD45和CD45RA、CD45RB,但不表达CD45RO。为了阐明这些骨髓瘤亚群的生物学特性,我们检测了Ki-67抗原的表达。增殖的骨髓瘤细胞(Ki-67+)存在于MPC-1-亚群和MPC-1-CD45+亚群中,而不是MPC-1-CD45-亚群中。接下来,为了进一步阐明两个未成熟亚群(MPC-1-CD45-CD49e-和MPC-1-CD45+CD49e-)的生物学差异,我们在体外与白细胞介素6(IL-6)共培养后测定细胞活力和表型变化。在IL-6存在的情况下,MPC-1-CD45+细胞比MPC-1-CD45-细胞保持更高的活力,并且一些MPC-1-CD45-细胞可以转化为MPC-1-CD45+细胞。总之,这些数据表明人类骨髓瘤细胞在表型上可分为五个亚群,在这些亚群中,MPC-1-CD45+CD49e-而非MPC-1-CD45-CD,49e-未成熟细胞含有对IL-6有反应的增殖细胞,并且IL-6还可诱导未成熟骨髓瘤细胞的MPC-1-CD45-亚群表达CD45。

相似文献

1
MPC-1-CD49e- immature myeloma cells include CD45+ subpopulations that can proliferate in response to IL-6 in human myelomas.MPC-1-CD49e-未成熟骨髓瘤细胞包括CD45+亚群,这些亚群在人类骨髓瘤中可对白细胞介素-6作出反应而增殖。
Br J Haematol. 1999 Apr;105(1):131-40.
2
Proliferation of immature myeloma cells by interleukin-6 is associated with CD45 expression in human multiple myeloma.
Leuk Lymphoma. 2000 Sep;39(1-2):51-5. doi: 10.3109/10428190009053538.
3
An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).骨髓浆细胞增多症进展期MPC-1及MPC-1-CD45+未成熟骨髓瘤细胞增多:单克隆骨髓浆细胞增多症的修订表型分类(MOMP-2005)
Int J Hematol. 2006 Jan;83(1):39-43. doi: 10.1532/IJH97.05112.
4
Growth mechanism of human myeloma cells by interleukin-6.白细胞介素-6介导的人骨髓瘤细胞生长机制
Int J Hematol. 2002 Aug;76 Suppl 1:329-33. doi: 10.1007/BF03165278.
5
Correlation between serum levels of free light chain and phenotype of plasma cells in bone marrow in primary AL amyloidosis.原发性AL淀粉样变性患者血清游离轻链水平与骨髓浆细胞表型的相关性
Amyloid. 2005 Mar;12(1):33-40. doi: 10.1080/02772240500032515.
6
The regulatory mechanism of IL-6-dependent proliferation of human myeloma cells.白细胞介素-6依赖的人骨髓瘤细胞增殖的调控机制
Hematology. 2003 Dec;8(6):409-11. doi: 10.1080/10245330310001621305.
7
Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization.人骨髓瘤细胞上的黏附分子:与恶性肿瘤、肿瘤扩散及永生化相关的表达显著变化
Cancer Res. 1995 Aug 15;55(16):3647-53.
8
Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells.
Haematologica. 2006 Jul;91(7):920-8.
9
Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation.白细胞介素-6、CD45与src激酶在骨髓瘤细胞增殖中的作用
Leuk Lymphoma. 2003 Sep;44(9):1477-81. doi: 10.3109/10428190309178767.
10
Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.利用CD19、CD45、CD56、CD38和CD138对多发性骨髓瘤患者骨髓浆细胞进行流式细胞术评估及其与骨髓浸润率的相关性
Saudi Med J. 2004 Nov;25(11):1587-92.

引用本文的文献

1
Dissecting immunophenotypic diversity in multiple myeloma via mass cytometry: a call for harmonized gating strategies.通过质谱流式细胞术剖析多发性骨髓瘤的免疫表型多样性:呼吁统一设门策略。
Front Immunol. 2025 Sep 4;16:1642609. doi: 10.3389/fimmu.2025.1642609. eCollection 2025.
2
Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.由 14q32/IGH 易位和另一个等位基因缺失引起的轻链浆细胞骨髓瘤。
Int J Hematol. 2019 May;109(5):572-577. doi: 10.1007/s12185-019-02629-7. Epub 2019 Mar 18.
3
Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.
免疫表型分析对硼替佐米治疗的多发性骨髓瘤患者预后的临床影响
Oncol Lett. 2017 May;13(5):3803-3808. doi: 10.3892/ol.2017.5920. Epub 2017 Mar 27.
4
Plasma cell maturity as a predictor of prognosis in multiple myeloma.浆细胞成熟度作为多发性骨髓瘤预后的预测指标
Med Oncol. 2016 Aug;33(8):87. doi: 10.1007/s12032-016-0803-3. Epub 2016 Jul 6.
5
Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.CD45异构体与STAT3、PKC和ERK的不同关联调节白细胞介素-6诱导的骨髓瘤增殖。
PLoS One. 2015 Mar 17;10(3):e0119780. doi: 10.1371/journal.pone.0119780. eCollection 2015.
6
Unfolded protein response inducers tunicamycin and dithiothreitol promote myeloma cell differentiation mediated by XBP-1.未折叠蛋白反应诱导剂衣霉素和二硫苏糖醇促进由XBP-1介导的骨髓瘤细胞分化。
Clin Exp Med. 2015 Feb;15(1):85-96. doi: 10.1007/s10238-013-0269-y. Epub 2013 Dec 20.
7
Plasma cell leukemia producing monoclonal immunoglobulin E.浆细胞白血病伴单克隆免疫球蛋白 E 生成。
Int J Hematol. 2009 Oct;90(3):402-406. doi: 10.1007/s12185-009-0407-1. Epub 2009 Aug 29.
8
Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death.用CNTO 328对白细胞介素-6进行靶向抑制可使多发性骨髓瘤的临床前模型对地塞米松介导的细胞死亡敏感。
Br J Haematol. 2009 May;145(4):481-90. doi: 10.1111/j.1365-2141.2009.07647.x. Epub 2008 Mar 6.
9
An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).骨髓浆细胞增多症进展期MPC-1及MPC-1-CD45+未成熟骨髓瘤细胞增多:单克隆骨髓浆细胞增多症的修订表型分类(MOMP-2005)
Int J Hematol. 2006 Jan;83(1):39-43. doi: 10.1532/IJH97.05112.
10
Interleukin-6-induced proliferation of human myeloma cells associated with CD45 molecules.白细胞介素-6诱导的与CD45分子相关的人骨髓瘤细胞增殖。
Int J Hematol. 2003 Aug;78(2):95-105. doi: 10.1007/BF02983376.